首页>外文期刊>医学、药学、卫生>内科学>Diabetes therapy

Diabetes therapy

SCIMEDLINE

中文名称：糖尿病治疗

ISSN：1869-6953
出版周期：-

发文量：1084

期刊论文

热门论文

年度选择

2021
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
2020
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2019
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第1asupplement期
2018
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2017
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2016
- 第1期
- 第2期
- 第3期
- 第4期
2015
- 第1期
- 第2期
- 第3期
- 第4期
2014
- 第1期
- 第2期
2013
- 第1期
- 第2期
2012
- 第1期
2011
- 第1期
- 第2期
- 第3期
2010
- 第1期
- 第2期

更多>>

全选（0）

1.Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China

机译：在中国新诊断患有2型糖尿病患者的事故并发症的直接医疗费用
- 作者：Xiaoning He;Yawen Zhang;Yan Zhou;Chaohui Dong;Jing Wu
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Diabetes complicationsDiabetes mellitusHealth care costsIncidenceType 2;
2.Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors

机译：每周杜拉蛋白在东亚患者2型糖尿病患者中的疗效和安全性：潜在影响因素的亚组分析
- 作者：Jianhua Ma;Bin Zhang;Jianing Hou;Yongde Peng
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- DulaglutideEast Asian patientsType 2 diabetes;
3.The “Early Treatment” Approach Reducing Cardiovascular Risk in Patients with Type?2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique

机译：“早期治疗”方法降低了2型糖尿病患者的心血管风险：使用Delphi技术的专家小组共识
- 作者：Giuseppina Russo;Matteo Monami;Gianluca Perseghin;Angelo Avogaro;Pasquale Perrone Filardi;Michele Senni;Claudio Borghi;Aldo P. Maggioni
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Delphi methodExpert consensusGLP-1 receptor agonistsGlucose-lowering agentsSGLT2 inhibitorsType?2 diabetes;
4.Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type?2 Diabetes in a US Real-World Setting

机译：Semaglutide曾经每周持续和粘附与其他糖尿病患者在美国真实世界的患者中的其他GLP-1 Ras
- 作者：Chioma Uzoigwe;Yuanjie Liang;Sarah Whitmire;Yurek Paprocki
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Diabetes mellitusGlucagon-like peptide 1Medication adherenceMedication persistenceSemaglutideType?2;
5.The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type?2 Diabetes and Established Cardiovascular Disease

机译：Empagliflozin的成本效益与类型糖尿病患者和建立心血管疾病的人群
- 作者：Lars Holger Ehlers;Mark Lamotte;Sofia Monteiro;Susanne Sandgaard;Pia Holmgaard;Evan C. Frary;Niels Ejskjaer
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Cardiovascular outcomesCost-effectivenessDiabetes type?2EmpagliflozinLiraglutide;
6.Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications

机译：患糖尿病缺失百万的风险预测：鉴定糖尿病患者高风险和相关并发症的个体
- 作者：Marc Evans;Angharad R. Morgan;Dipesh Patel;Ketan Dhatariya;Sharlene Greenwood;Philip Newland-Jones;Debbie Hicks;Zaheer Yousef;Jim Moore;Bethany Kelly;Sarah Davies;Umesh Dashora
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Chronic kidney diseaseDiabetes-related complicationsHeart failureRisk predictionType?2 diabetes;
7.Linear Projection of Estimated Glomerular Filtration Rate Decline with Canagliflozin and Implications for Dialysis Utilization and Cost in Diabetic Nephropathy

机译：估计肾小球过滤速率的线性投影与蜜胶增生率下降及糖尿病肾病的透析利用率和成本的影响
- 作者：Michael Durkin;Jaime Blais
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- CanagliflozinCost of illnessDiabetes mellitusType 2DialysisRenal insufficiencychronicSodium glucose co-transporter 2 inhibitors;
8.Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin

机译：胰岛素Aspart BioSimilar SAR341402的功效，安全性和免疫原性与糖尿病（Gemelli 1）的成人发起胰岛素Aspart相比：通过现有的膳食胰岛素的亚组分析
- 作者：Viral N. Shah;Edward Franek;Karin Wernicke-Panten;Suzanne Pierre;Bhaswati Mukherjee;Karita Sadeharju
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Biosimilar insulinGEMELLI 1Insulin aspartSAR341402Subgroup by prior mealtime insulin;
9.Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes

机译：增加二甲双胍剂量对二肽肽酶-4型糖尿病患者血糖控制抑制剂的影响
- 作者：Yoshio Nagai;Kiyoyasu Kazumori;Tomomi Takeshima;Kosuke Iwasaki;Yasushi Tanaka
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Claims databaseCombination drug therapyDipeptidyl peptidase-4 inhibitorsDose increasedDrug switchGlycated hemoglobin AGlycemic controlHypoglycemic agentsMetforminType 2 diabetes;
10.Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type?1 Diabetes in Sweden: A Cost-Effectiveness Analysis

机译：智能胰岛素笔与瑞典类型的较低成本与较低的临床结果相关联，瑞典的1型糖尿病：一种成本效益分析
- 作者：Johan Jendle;?sa Ericsson;Jens Gundgaard;Jonas Bech M?ller;William J. Valentine;Barnaby Hunt
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Diabetes complicationsDiabetes self-managementDiabetes technologyDigital healtheHealthHealth technology assessmentHealthcare economicsHypoglycemiaInsulin therapyType?1 diabetes;
11.New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry

机译：Covid-19中的新出售糖尿病：时间框架令人恐惧的对称性
- 作者：Stella Papachristou;Iliana Stamatiou;Anca P. Stoian;Nikolaos Papanas
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Corona virus infectious diseaseDiabetes mellitusKetoacidosisNew-onset diabetes;
12.Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study

机译：基于治疗窘迫，满意度和自我疗效的日本2型糖尿病患者患者LED和医生-ED胰岛素滴定的比较：提交患者研究
- 作者：Hitoshi Ishii;Hiroki Nakajima;Nozomu Kamei;Daigaku Uchida;Daisuke Suzuki;Yasuhiro Ono;Yasunori Sato;Dai Shimono
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Emotional distressInsulinPatient-led insulin self-titrationPatient-reported outcomePhysician-led insulin titrationQuality of lifeSelf-efficacySelf-managementTreatment satisfaction;
13.Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

机译：二次护理糖尿病中半蛋白质的现实世界临床经验：回顾性观测研究
- 作者：David M. Williams;Aliya M. Ruslan;Rahim Khan;Daneeshanan Vijayasingam;Fizzah Iqbal;Ayesha Shaikh;Jia Lim;Richard Chudleigh;Rajesh Peter;Maneesh Udiawar;Stephen C. Bain;Jeffrey W. Stephens;Thinzar Min
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Glucagon-like peptide-1 receptor analoguesGlycaemic controlSemaglutideType 2 diabetesWeight loss;
14.Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel

机译：在糖尿病患者管理中的个性化的延伸范围和胰岛素的作用：跨国小组的临床见解
- 作者：Sanjay Kalra;Shehla Shaikh;Gagan Priya;Manas P. Baruah;Abhyudaya Verma;Ashok K. Das;Mona Shah;Sambit Das;Deepak Khandelwal;Debmalya Sanyal;Sujoy Ghosh;Banshi Saboo;Ganapathi Bantwal;Usha Ayyagari;Daphne Gardner;Cecilia Jimeno;Nancy E. Barbary;Khadijah A. Hafidh;Jyoti Bhattarai;Tania T. Minulj;Hendra Zufry;Uditha Bulugahapitiya;Moosa Murad;Alexander Tan;Selim Shahjada;Mijinyawa B. Bello;Prasad Katulanda;Gracjan Podgorski;Wajeeha I. AbuHelaiqa;Rima Tan;Ali Latheef;Sedeshan Govender;Samir H. Assaad-Khalil;Cecilia Kootin-Sanwu;Ansumali Joshi;Faruque Pathan;Diana A. Nkansah
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Clinical insightsContinuous glucose monitoringDiabetesGlycemic variabilityHypoglycemiaInsulin degludecInsulin detemirInsulin glargine 100 U/mLInsulin glargine 300 U/mLInsulin therapySecond-generation basal insulinTime-in-range;
15.Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

机译：Liraglutide对2型糖尿病患者非酒精性脂肪肝病的影响：系统审查和荟萃分析
- 作者：Tiantian Song;Yujiao Jia;Zelin Li;Fei Wang;Luping Ren;Shuchun Chen
- 期刊名称：《Diabetes therapy》 | 2021年第6期
- LiraglutideMeta-analysisNonalcoholic fatty liver diseaseSystematic reviewType 2 diabetes mellitus;
16.Risk Factors for Albuminuria in Normotensive Older Adults with Type 2 Diabetes Mellitus and Normal Renal Function: A Cross-Sectional Study

机译：患有2型糖尿病和常规肾功能的患有2型糖尿病患者的白蛋白尿危险因素及肾功能：横截面研究
- 作者：Yingyi Zhou;Ke Chen;Xuan Du;Jiali Tang;Bimin Shi
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Albumin to creatinine ratioElderlyHypertensionInsulin resistanceRenal functionType 2 diabetes mellitus;
17.Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

机译：苏磺酰脲单药治疗的糖尿病患者腹腔不济型患者的疗效和安全性：Vertis CV的替换物
- 作者：Krzysztof Strojek;A. Shekhar Pandey;Vanessa Dell;Melanie Sisson;Shuai Wang;Susan Huyck;Jie Liu;Ira Gantz
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- GlycemicHbA1cSecondary preventionSGLT2 inhibitorSodium-glucose cotransporter 2 inhibitorType 2 diabetes mellitus;
18.Efficacy and Safety of Luseogliflozin in Patients with Type?2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial

机译：Luseogliflozin在肝功能障碍复杂化患者中Luseogliflozin的疗效和安全性：单个网站，单臂，开放标签，探索性试验
- 作者：Hiroaki Seino
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Hepatic dysfunctionLuseogliflozinSGLT2 inhibitorType?2 diabetes mellitus;
19.Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

机译：长期成本效益Dexcom G6实时连续葡萄糖监测系统与法国1型糖尿病人的血糖自我监测相比
- 作者：Stéphane Roze;John J. Isitt;Jayne Smith-Palmer;Peter Lynch;Brigitte Klinkenbijl;Gerald Zammit;Pierre-Yves Benhamou
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Cost-effectivenessFranceReal-time continuous glucose monitoringType 1 diabetes;
20.Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

机译：Empagliflozin在非酒精性脂肪肝疾病和2型糖尿病患者中提高肝脏脂肪变性和纤维化：随机，双盲，安慰剂控制的临床试验
- 作者：Haleh Chehrehgosha;Masoud Reza Sohrabi;Faramarz Ismail-Beigi;Mojtaba Malek;Mohammad Reza Babaei;Farhad Zamani;Hossein Ajdarkosh;Mahmood Khoonsari;Afshin Eshghi Fallah;Mohammad E. Khamseh
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Body compositionEmpagliflozinFibroscanLiver fibrosisNon-alcoholic fatty liver disease (NAFLD)Nonalcoholic steato-hepatitis (NASH)PioglitazoneSteatosis;
21.African Cuisine-Centered Insulin Therapy: Expert Opinion on the Management of Hyperglycaemia in Adult Patients with Type 2 Diabetes Mellitus

机译：以非洲美食为中心的胰岛素疗法：2型糖尿病患者高血糖症管理的专家意见
- 作者：Jean Claude Mbanya;Roberta Lamptey;Andrew E. Uloko;Amos Ankotche;Gontle Moleele;Gaman Ali Mohamed;Iswaraj Ramracheya;Kaushik Ramaiya;Malusi Ndiweni;Ma?mouna Ndour Mbaye;Silver Bahendeka;Sanjay Kalra
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- African cuisineCarbohydrateInsulin therapyMeal patternType 2 diabetes;
22.Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis

机译：单独对二甲双胍的2型糖尿病中加入口腔抗血糖药物的相对疗效及单一的抗血糖药物仅对二甲双胍（Symens）综述和网络荟萃分析
- 作者：Dominik Lautsch;Adnan Alsumali;Euan McLeod;Yuting Kuang;Jing He;Rajpal Singh;Arianna Nevo;Urs Arnet;Jennifer Uyei;Swapnil Rajpathak
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Dual initiationNetwork meta-analysisOral antihyperglycemic agentType 2 diabetes;
23.Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion?from an Indian Panel

机译：在Covid-19大流行期间与基础类似物的T2DM胰岛素化：专家意见？来自印度小组
- 作者：Manoj Chawla;Sunil M. Jain;Jothydev Kesavadev;Brij M. Makkar;Vijay Viswanathan;Mangesh Tiwaskar;Aravind R. Sosale;Vijay Negalur;Kirtikumar D. Modi;Mukulesh Gupta;Surinder Kumar;Santosh Ramakrishnan;Nilakshi Deka;Nirmalya Roy
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Basal insulin analoguesCOVID-19DiabetesInsulin degludecInsulin detemirInsulin glargine 100 U/mLInsulin glargine 300 U/mLInsulin initiation during pandemicTitration;
24.Sodium–Glucose Co-Transporter?2 Inhibitors (SGLT2i) Exposure and Outcomes in Type?2 Diabetes: A Systematic Review of Population-Based Observational Studies

机译：钠 - 葡萄糖共转运蛋白？2型糖尿病（SGLT2i）的抑制剂（SGLT2i）β2糖尿病的暴露和结果：对基于人口的观察研究进行了系统审查
- 作者：Thomas M. Caparrotta;Andrew M. Greenhalgh;Karen Osinski;Robert M. Gifford;Svenja Moser;Sarah H. Wild;Rebecca M. Reynolds;David J. Webb;Helen M. Colhoun
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- Comparative effectivenessObservational studiesSGLT2 inhibitorsSystematic reviewType?2 diabetes;
25.Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type?2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis

机译：经皮冠状动脉干预的十年结果与冠状动脉旁路接枝术患者患者患者患者患有左主要冠状动脉疾病：META分析
- 作者：Hong Wang;Hongli Wang;Yuyuan Wei;Xinxin Li;Vineet Jhummun;Mohamad A. Ahmed
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- Cardiovascular diseaseCoronary artery bypass graftingLeft main coronary diseaseLong-term outcomesPercutaneous coronary interventionRevascularization therapiesType?2 diabetes mellitus;
26.Movement is Improvement: The Therapeutic Effects of Exercise and General Physical Activity on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

机译：运动是改进：运动和一般身体活动对2型糖尿病患者血糖控制的治疗效果：随机对照试验的系统审查和荟萃分析
- 作者：Sayed Z. A. Shah;Jawad A. Karam;Alam Zeb;Rafi Ullah;Arif Shah;Ijaz Ul Haq;Iftikhar Ali;Haider Darain;Hong Chen
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Diabetes mellitustype 2ExerciseFasting blood glucoseGlycated hemoglobinMeta-analysisPhysical activitySystematic review;
27.Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin? ?GLP-1 Receptor Agonist Combination Therapies

机译：基于Delphi的治疗强化共识2型糖尿病受试者失败的基础胰岛素支持口服治疗：专注于基础胰岛素？？GLP-1受体激动剂组合疗法
- 作者：Gian Paolo Fadini;Olga Disoteo;Riccardo Candido;Paolo Di Bartolo;Luigi Laviola;Agostino Consoli
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Basalinsulin? ?GLP-1RA combination therapiesBasal oral therapyDelphi methodExpert consensusInsulin intensificationType 2 diabetes;
28.Prevalence of Incretin-Mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2 Diabetics Following Myocardial Revascularization: An Observational Study

机译：德国住院2型糖尿病患者Incetin模拟物和钠 - 葡萄糖转运蛋白-2-抑制剂治疗患病率：观察研究
- 作者：Rainer U. Pliquett;Linda Golle;Andreas Wienke;Matthias Girndt
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Diabetes mellitusHypoglycemiaIncretin mimeticsInsulinSodium glucose transporter-2 inhibitors;
29.One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

机译：一年的Dapaglifozin附加疗法改善了2型糖尿病患者胰岛素抵抗和肥胖的替代指标
- 作者：Stefano Radellini;Enrica Vigneri;Valentina Guarnotta;Felicia Panto;Carla Giordano
- 期刊名称：《Diabetes therapy》 | 2021年第6期
- LAPDapagliflozinVisceral adiposity indexCardiometabolic riskTyg;
30.A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA

机译：跨美国卫生保健组织各种糖尿病管理治疗惯性的回顾性分析
- 作者：Cori R. Rattelman;Elizabeth L. Ciemins;Nikita Stempniewicz;Michelle Mocarski;Rahul Ganguly;John K. Cuddeback
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Clinical inertiaElectronic health recordsHealth systemIntegrated delivery networkTherapeutic inertiaTreatment intensificationType 2 diabetes;
31.Application of Telemedicine in Diabetes Care: The Time is Now

机译：远程医疗在糖尿病护理中的应用：现在的时间
- 作者：Felix Aberer;Daniel A. Hochfellner;Julia K. Mader
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- DiabetesTelecareTelediabetologyTelehealth;
32.Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

机译：糖尿病患者胰岛素青氯素切换快速胰岛素的有效性和安全性：观察IGLU-S研究
- 作者：Jochen Seufert;Martin Pfohl;Anja Borck;Peter Bramlage;Thorsten Siegmund
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Blood glucoseDiabetesHbA1cHypoglycaemiaInsulin;
33.Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study

机译：空腹血糖和2-H后血糖预测高血压：来自反应研究的报告
- 作者：Yingkui Si;Anping Wang;Yunshuang Yang;Hongzhou Liu;Shi Gu;Yiming Mu;Zhaohui Lyu
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- 2-h postprandial glucoseFasting blood glucoseGlycated hemoglobinHypertensionPrediabetes;
34.Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5?kg/m 2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study

机译：中国患有2型糖尿病的患者，体重指数为27.5-32.5〜7.5-32.5‰吗？KG / M 2适用于代谢手术？一年的手术后学习
- 作者：Ning-Jing Zhang;Yu-Zhe Fu;Xiao-Dong Shan;Ning Zhang;Xi-Tai Sun;Xue-Hui Chu;Yan Bi;Da-Long Zhu;Wen-Huan Feng
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Body mass indexMetabolic surgeryType 2 diabetes;
35.A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK

机译：对痛苦糖尿病患者进行心理方面的考虑：对英国大专院校止痛管理服务的洞察
- 作者：Hannah Twiddy;Bernhard Frank;Uazman Alam
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- Acceptance and commitment therapyAnxietyCognitive behavioural therapyDepressionPainful diabetic neuropathyPain management programme;
36.Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset

机译：治疗2型糖尿病患者入射心血管合并症的指南依从性和相关结果：基于德国索赔数据集的分析
- 作者：Maximilian Gabler;Nils Picker;Silke Geier;Ludwin Ley;Jens Aberle;Michael Lehrke;Stephan Martin;Matthias Riedl;Thomas Wilke
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- Cardiovascular diseaseCardiovascular drug treatmentGuideline adherenceT2DM;
37.Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes

机译：2型糖尿病患者慢性肾病早期筛查和诊断的重要性
- 作者：Neil S. Skolnik;Alyssa J. Style
- 期刊名称：《Diabetes therapy》 | 2021年第6期
- AlbuminuriaDiabetes mellitusType 2Glomerular filtration rateGlucagon-like peptide 1 receptor agonistsRenal insufficiencyChronicRenin–angiotensin systemSodium–glucose?cotransporter-2 inhibitorsUACR;
38.Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study

机译：2型糖尿病患者口服葡萄糖降低剂的时间：回顾性队列研究
- 作者：Kristina S. Boye;Maureen J. Lage;Jacek Kiljański
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Clinical inertiaGlucose-lowering-agentsGlycemic burdenHbA1cKaplan–Meier analysesOral therapyType 2 diabetes;
39.Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type?2 Diabetes

机译：糖尿病和脆弱：关于使用类型的老年人管理的专家共识声明？2型糖尿病
- 作者：W. David Strain;Su Down;Pam Brown;Amar Puttanna;Alan Sinclair
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- ElderlyFrailtyTreatment choicesType 2 diabetes;
40.Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)

机译：胰高血糖素肽-1受体激动剂在日本2型糖尿病中的使用：回顾性数据库分析（JDDM 57）
- 作者：Yasushi Ishigaki;Alena Strizek;Toshihiko Aranishi;Nobuhiro Arai;Takeshi Imaoka;Zhihong Cai;Hiroshi Maegawa
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Diabetes mellitustype 2Glucagon-like peptide-1 receptor agonistRegistryTreatment persistence;
41.Impact of Intensive Glucose Control on Brain Health: Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus

机译：强化葡萄糖控制对脑健康的影响：16,584型糖尿病患者的累积数据荟萃分析
- 作者：Xingyao Tang;Marly A. Cardoso;Jinkui Yang;Jian-Bo Zhou;Rafael Simó
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Brain healthDiabetesIntensive glucose control;
42.Personality Traits, Metabolic Control and the Use of Insulin Pump Functions in Adults With Type 1 Diabetes: An Observational Single-Visit Study

机译：患有1型糖尿病的人格特征，代谢控制和胰岛素泵功能的使用：观察单一学习
- 作者：Agnieszka Niemiec;Agata Juru?;Piotr Mol?da;Krzysztof Safranow;Lilianna Majkowska
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- Hypoglycaemic episodesInsulin pump treatmentMetabolic controlPersonality traitsType 1 diabetes;
43.Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

机译：年龄对胰岛素巨石300 u / ml的有效性和安全的影响：Reali欧洲汇总数据分析的结果
- 作者：Riccardo C. Bonadonna;Didac Mauricio;Dirk Müller-Wieland;Nick Freemantle;Gregory Bigot;Celine Mauquoi;Alice Ciocca;Mireille Bonnemaire;Pierre Gourdy
- 期刊名称：《Diabetes therapy》 | 2021年第4期
- AgeEuropeGlycaemic controlHypoglycaemiaInsulin glargine 300 U/mLOlder adultsPooled analysisType 2 diabetes;
44.Real-World Effectiveness and Safety of Insulin Glargine 300?U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study

机译：胰岛素冰柱300的实际效力和安全性，T2D患者U / ml在NPH或预混合的胰岛素上不受控制，作为保加利亚的常规临床实践的一部分：Touprade研究
- 作者：Zdravko Kamenov;Veselina Pehlivanova;Tsvetodara Kuneva;Kiril Kirilov;Roza Bobeva;Julija Stoykova;Svetla Mihalevska
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Basal insulinsInsulin glargine 300?U/mLObservational studyRoutine clinical practiceReal-life effectivenessToUPGRADEType?2 diabetes;
45.Inpatient Hyperglycemia Management and COVID-19

机译：住院性高血糖管理和Covid-19
- 作者：Virginia Bellido;Antonio Pérez
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- COVID-19DiabetesHospitalizedHyperglycemiaInpatientInsulin therapySARS-CoV-2;
46.Diabetes and Bone Fragility

机译：糖尿病和骨脆弱性
- 作者：Camila Romero-Díaz;Daniela Duarte-Montero;Sebastián A. Gutiérrez-Romero;Carlos O. Mendivil
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- BoneBonesDenosumabDiabetes mellitusFracturesOsteoporosis;
47.Glucagon-Like Peptide?1 Receptor Agonists in Type?2 Diabetes Mellitus: Data from a Real-World Study in Spain

机译：胰高血糖素肽？1型糖尿病的1个受体激动剂：来自西班牙的真实研究的数据
- 作者：Kirsi Norrbacka;Antoni Sicras-Mainar;Jeremie Lebrec;Esther Artime;Silvia Díaz;Santiago Tofé-Povedano;Ignacio Hernández;Irene Romera
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- CostsGlucagon-like peptide?1 receptor agonists (GLP-1?RAs)Persistence with treatmentReal-world evidence (RWE)Resource utilizationSpainType?2 diabetes mellitus;
48.Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type?1 Diabetes: The PRONTO-T1D Extension

机译：具有型型糖尿病型成人的超快速LISPRO（URLI）的长期疗效和安全性：PRONTO-T1D延伸
- 作者：Juliana Bue-Valleskey;Leslie Klaff;Jang Ik Cho;Mary Anne Dellva;Nanette C. Schloot;Janet Tobian;Junnosuke Miura;Dominik Dahl
- 期刊名称：《Diabetes therapy》 | 2021年第2期
- LisproType?1 diabetesUltra rapid lispro;
49.Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study

机译：在以色列SARS-COV-2大流行病的第一个月介绍急诊部门介绍的糖尿病酮症症：多中心横断面研究
- 作者：Ron Jacob;Giora Weiser;Danna Krupik;Dania Takagi;Shuny Peled;Naama Pines;Saar Hashavya;Hagar Gur-Soferman;Shirly Gamsu;Or Kaplan;Michal Maimon;Shahar Oren;Gabi Padeh;Itai Shavit
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- CoronavirusDiabetesKetoacidosisPandemic;
50.A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes

机译：基于2型糖尿病的基础推注或预混胰岛素的启动，使用和有效性的现实世界，观察性研究
- 作者：Hideaki Miyoshi;Mike Baxter;Takeshi Kimura;Masakatsu Hattori;Yukiko Morimoto;Dion Marinkovich;Masami Tamiwa;Takahisa Hirose
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Basal-bolus insulin therapyInsulin therapy initiationJapanese people with type 2 diabetesPremixed insulin therapyReal-world study;
51.Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails

机译：基线HBA1C水平影响牙周治疗对2型糖尿病和牙周炎人群的血糖控制的影响：对随机控制小径的系统审查
- 作者：Ya-fei Chen;Qi Zhan;Chen-zhou Wu;Yi-hang Yuan;Wen Chen;Fan-yuan Yu;Yi Li;Long-jiang Li
- 期刊名称：《Diabetes therapy》 | 2021年第5期
- Blood glucoseDiabetes mellitustype 2Meta-analysisPeriodontitisScaling and root planingSystematic review;
52.Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN

机译：在禁食期间用Gliclazide MR治疗2型糖尿病患者真实研究的描述性区域细胞分析：DIA-Ramadan
- 作者：Mohamed Hassanein;Saud Al Sifri;Shehla Shaikh;Syed Abbas Raza;Javed Akram;Achmad Rudijanto;Inass Shaltout;Fariduddin;Wan Mohd Izani Bin Wan Mohamed;Fatheya Al Awadi;Alexandra Durocher;Viviana Cortese;Thamer Alessa
- 期刊名称：《Diabetes therapy》 | 2021年第6期
- Diabetes mellitusFastingGliclazideRamadanType 2;
53.A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience

机译：基础和中间混合物胰岛素的务实研究作为中国2型糖尿病患者的起动胰岛素：长期观测，现实世界经验
- 作者：Tianshu Zeng;Huijuan Yuan;Jiangong Ren;Yuanyuan Li;Jianing Hou;Liying Du;Jiankun Zhu;Lulu Chen;Linong Ji
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Basal insulinChinese patientsPremixed insulinReal-world studyType 2 diabetes;
54.A Comparison of Validated Methods Used to Assess Impaired Awareness of Hypoglycaemia in Type?1 Diabetes: An Observational Study

机译：验证方法的比较评估1型糖尿病患者的低血糖对低血糖意识的影响：观察研究
- 作者：Kshitiz Ghandi;Beatrice Pieri;Anne Dornhorst;Sufyan Hussain
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- HypoglycaemiaHypoglycaemia unawarenessImpaired awareness of hypoglycaemiaType?1 diabetes;
55.Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes

机译：老年胰岛素治疗患者的脂糖性患者2型糖尿病患者
- 作者：Sandro Gentile;Giuseppina Guarino;Teresa Della Corte;Giampiero Marino;Alessandra Fusco;Gerardo Corigliano;Sara Colarusso;Marco Piscopo;Maria Rosaria Improta;Marco Corigliano;Emilia Martedi;Domenica Oliva;Viviana Russo;Rosa Simonetti;Ersilia Satta;Carmine Romano;Sebastiano Vaia;Felice Strollo
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- AgeingDiabetesInsulinLipohypertrophySkin;
56.Nutritional Status of Pediatric Patients with Type 1 Diabetes Mellitus from Northeast Poland: A Case-Control Study

机译：波兰东北部1型糖尿病儿科患者的营养状况：案例对照研究
- 作者：Monika Grabia;Renata Markiewicz-?ukowska
- 期刊名称：《Diabetes therapy》 | 2021年第1期
- AdolescentsBioelectrical impedance analysisInsulin therapyMetabolic managementNutritional behaviors;
57.Risk Prediction Model of Gestational Diabetes Mellitus in a Chinese Population Based on a Risk Scoring System

机译：基于风险评分系统的中国人群妊娠期糖尿病风险预测模型
- 作者：Yanmei Wang;Zhijuan Ge;Lei Chen;Jun Hu;Wenting Zhou;Shanmei Shen;Dalong Zhu;Yan Bi
- 期刊名称：《Diabetes therapy》 | 2021年第6期
- Early pregnancyGestational diabetesPrediction modelRisk score;
58.What’s in a Name? Redefining Type 2 Diabetes Remission

机译：什么是名字？重新定义2型糖尿病缓解
- 作者：Sanjay Kalra;Arbinder Singal;Tejal Lathia
- 期刊名称：《Diabetes therapy》 | 2021年第3期
- Calorie restriction mimicryCureEuglycemiaLifestyle modificationMetforminRemission of diabetesReversal of diabetesType 2 diabetes;
59.Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis

机译：不同葡萄糖降低措施对妊娠糖尿病孕妇孕妇和婴儿结果的影响：网络元分析
- 作者：Ouyang Hong;Wu Na
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- MetforminInsulinGlyburideDiet and exerciseGestational diabetesMaternal and infant outcomeRandomized controlled trials;
60.The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin

机译：维拉帕米对TXNIP基因表达，GLP1R mRNA，FBS，HBA1C和脂质谱系在T2DM患者接受二甲双胍和SITAGLIPTIN中的影响
- 作者：Malayeri Alireza;Zakerkish Mehrnoosh;Ramesh Farrokh;Galehdari Hamid;Hemmati Ali Asghar;Angali Kambiz A.
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Type 2 diabetesRandomized controlled trialsVerapamilTXNIP;
61.Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results

机译：糖尿病研究中的随机对照试验：解释公布结果的途径
- 作者：Battelino Tadej;Mauricio Didac
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Randomised controlled trialPublicationsInterpretationCONSORT;
62.Prevalence and Metabolic Predictors for Early Diagnosed Prediabetes in Women with Previous Gestational Diabetes: Observational Cohort Study

机译：早期诊断患有先前妊娠期糖尿病的妇女早期诊断的患病率和代谢预测因子：观察队列研究
- 作者：Jotic Aleksandra Z.;Stoiljkovic Milica M.;Milicic Tanja J.;Lalic Katarina S.;Lukic Ljiljana Z.;Macesic Marija V.;Stanarcic Gajovic Jelena N.;Milovancevic Mina M.;Gojnic Dugalic Miroslava G.;Jeremic Veljko M.;Lalic Nebojsa M.
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Previous gestational diabetesPrevalence and metabolic predictors for prediabetes;
63.Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors

机译：持续每周杜拉蛋白酶患者患者2型糖尿病患者的胰腺安全性：潜在影响因素的亚组分析
- 作者：Zhou Yan;Zhu Jiankun;Wu Haiya;Deng Yuying;Ji Qiuhe
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Chinese patientDulaglutidePancreatic safetySubgroup analysisType 2 diabetes;
64.The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study

机译：平均血糖血红蛋白或血糖变异性与糖尿病人类视网膜病变的关系：回顾性观察队列研究
- 作者：Dhatariya Ketan;Humberstone Alexander;Hasnat Abul;Wright Rebecca;Lujan Morgan;Nunney Ian
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Diabetic retinopathyGlycaemic variabilityHbA1cRisk;
65.Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy

机译：鉴定不恰当的临床行动（别）改善2型糖尿病患者的管理失败，失败基础胰岛素支持口服治疗：意大利糖尿病专家小组调查结果
- 作者：Leto Gaetano;Barchetta Ilaria;De Candia Lorenzo;Magotti Maria Grazia;Cianciullo Marco;Manti Roberta;Negri Carlo;Cimino Vincenzo;Dodesini Alessandro R.;Zerella Francesco;Baratta Roberto
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Type 2 diabetesBasal insulin supported oral therapyTreatment intensificationPatient communication;
66.Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11

机译：胃肠道耐受性持续每周杜拉加仑3.0毫克和4.5毫克：恶心，呕吐和腹泻的发病率和患病率的后HOC分析 - 11
- 作者：Van Joanna;Frias Juan P.;Bonora Enzo;Raha Sohini;Meyer Jarrett;Jung Heike;Cox David;Konig Manige;Peleshok Jennifer;Bethel M. Angelyn
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- DulaglutideGastrointestinalGlucagon like peptide-1 (GLP-1) agonistNauseaTolerabilityType 2 diabetes;
67.Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked

机译：作为糖尿病人类的成因表和/或患有糖尿病的神经病变的醇的消费经常被忽视
- 作者：Bell David S. H.;Goncalves Edison
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Diabetic neuropathyAlcoholic neuropathyEthyl Glucuronide;
68.Comparison of Body Mass Index and Waist Circumference in the Prediction of Diabetes: A Retrospective Longitudinal Study

机译：糖尿病预测中体重指数和腰围的比较：回顾性纵向研究
- 作者：Abe Makiko;Fujii Hideyuki;Funakoshi Shunsuke;Satoh Atsushi;Kawazoe Miki;Maeda Toshiki;Tada Kazuhiro;Yokota Soichiro;Yamanokuchi Toshitaka;Yoshimura Chikara;Mimata Ryosuke;Takahashi Koji;Ito Kenji;Yasuno Tetsuhiko;Kuga Takeshi;Mukoubara Shigeki;Akiyoshi Kozaburo;Kawanami Daiji;Masutani Kosuke;Arima Hisatomi
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Body mass indexWaist circumferenceDiabetesObesity;
69.Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type?1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy

机译：新诊断型患者外源性胰岛素抗体综合征的发展1糖尿病用口服免疫抑制单药治疗
- 作者：Jerkins Terri;Bell David S. H.
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Type?1 diabetesInsulin antibodiesOral immunosuppressantsExogenous insulin antibody syndrome;
70.The Therapeutic Effects of Mild to Moderate Intensity Aerobic Exercise on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Trials

机译：温和至中等强度好氧运动对2型糖尿病患者血糖控制的治疗作用：随机试验的荟萃分析
- 作者：Gao Siyao;Tang Jialing;Yi Guozhong;Li Zhong;Chen Zhenyin;Yu Ling;Zheng Feng;Hu Yajing;Tang Zhangui
- 期刊名称：《Diabetes therapy》 | 2021年第10期
- Type 2 diabetes mellitusAerobic exerciseGlycemic controlGlycosylated hemoglobin;
71.Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study

机译：远程监控程序的影响包括2型糖尿病中的生活方式教育软件：教育结果@ DOM随机化多期面研究
- 作者：Turnin Marie-Christine;Gourdy Pierre;Martini Jacques;Buisson Jean-Christophe;Chauchard Marie-Christine;Delaunay Jacqueline;Schirr-Bonnans Solène;Taoui Soumia;Poncet Marie-France;Cosma Valeria;Lablanche Sandrine;Coustols-Valat Magali;Chaillous Lucie;Thivolet Charles;Sanz Caroline;Penfornis Alfred;Lepage Beno?t;Colineaux Hélène;Mounié Micha?l;Costa Nadège;Molinier Laurent;Hanaire Hélène
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Type 2 diabetesLifestyle managementGlucose controlTelemonitoringTele-educationHealth-related objects;
72.Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes

机译：社会经济因素和性别对1型糖尿病患者的脂质降低治疗的补充依赖性和持续性的影响
- 作者：Hero Christel;Karlsson Sofia Axia;Franzén Stefan;Svensson Ann-Marie;Miftaraj Mervete;Gudbj?rnsdottír Soffia;Andersson-Sundell Karolina;Eliasson Bj?rn;Eeg-Olofsson Katarina
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- AdherencePersistenceSocioeconomySocioeconomic statusLipid-lowering therapyStatin therapyType 1 diabetes;
73.Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019

机译：2型糖尿病患者的HBA1C和体重指数的趋势：来自美国数据库2012-2019的证据
- 作者：Boye Kristina S.;Lage Maureen J.;Shinde Shraddha;Thieu Vivian;Bae Jay Patrick
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Body mass indexHbA1cTrendsType 2 diabetes;
74.Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus

机译：Empagliflozin对安慰剂对急性心肌梗死患者等血浆体积状态的影响及2型糖尿病
- 作者：Hoshika Yu;Kubota Yoshiaki;Mozawa Kosuke;Tara Shuhei;Tokita Yukichi;Yodogawa Kenji;Iwasaki Yu-ki;Yamamoto Takeshi;Takano Hitoshi;Tsukada Yayoi;Asai Kuniya;Miyamoto Masaaki;Miyauchi Yasushi;Kodani Eitaro;Maruyama Mitsunori;Tanabe Jun;Shimizu Wataru
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- Acute myocardial infarctionCongestive heart failureEmpagliflozinPlasma volume statusSodium-glucose cotransporter 2 (SGLT2) inhibitor;
75.The Role of Finerenone in the Management of Diabetic Nephropathy

机译：Finerenone在糖尿病肾病管理中的作用
- 作者：Veneti Stavroula;Tziomalos Konstantinos
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- AlbuminuriaDiabetic kidney diseaseDiabetic nephropathyFinerenoneMineralocorticoid receptor antagonistsType?2 diabetes mellitus;
76.Episodic Real-Time CGM Use in Adults with Type?2 Diabetes: Results of a Pilot Randomized Controlled Trial

机译：集体实时CGM在成人中使用类型？2糖尿病：试点随机对照试验的结果
- 作者：Price David A.;Deng Qianqian;Kipnes Mark;Beck Stayce E.
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Episodic continuous glucose monitoringHbA1cOral antihyperglycemic medicationsT2D;
77.SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type?2 Diabetes: A Narrative Review

机译：SGLT2抑制剂和相关体重减轻的临床意义2糖尿病：叙述审查
- 作者：Jane? Andrej;Fioretto Paola
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- CVOTSGLT2 inhibitorsType?2 diabetesWeight loss;
78.Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study

机译：用现场护理点血红蛋白A1C测试评估患者满意度：观察研究
- 作者：Al Hayek Ayman A.;Al-Saeed Abdulghani H.;Alzahrani Wael M.;Al Dawish Mohamed A.
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- DiabetesPoint of carePOCTPSQ-18HbA1cSaudi Arabia;
79.Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation

机译：各种计量条件对口服半蛋白质药代动力学的影响，一种平板制剂中的人胰高血糖素样肽-1类似物
- 作者：B?kdal Tine A.;Breitschaft Astrid;Donsmark Morten;Maarbjerg Stine J.;S?ndergaard Flemming L.;Borregaard Jeanett
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Dosing conditionsFood effectGlucagon-like peptide-1Oral semaglutidePharmacokineticsSodium N-(8-2-hydroxybenzoyl?amino)?caprylate;
80.The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type?2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

机译：杜拉格替纳和黎射叶蛋白患者的真实观测治疗健康结果的前瞻性研究？2糖尿病患者（奖杯）：设计和基线特征
- 作者：García-Pérez Luis-Emilio;Boye Kristina S.;Rosilio Myriam;Jung Heike;Heitmann Elke;Norrbacka Kirsi;Federici Marco Orsini;Gentilella Raffaella;Guerci Bruno;Giorgino Francesco;Aigner Ulrich;Sapin Hélène
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- DulaglutideGlucagon-like peptide?1 receptor agonistsInjectable therapyLiraglutideObservational study designPatient characteristicsType?2 diabetes;
81.Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes

机译：Iglarlixi的有效性，胰岛素龟甲100 U / ml和Lixisenatide的固定比例，2型糖尿病
- 作者：Kis János Tibor;Nagy Gábor;Kovacs Gábor
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- Type 2 diabetesFixed-ratio combinationInsulin glargine and lixisenatideNon-interventional study;
82.A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type?2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

机译：基于索赔的队列的队列型患者型患者2型糖尿病患者和早期第一次医生参观的协会，随着时间的推移口服降糖药物
- 作者：Watada Hirotaka;Kawakita Yasushi;Tanaka Keiko;Oh Akinori;Nishigaki Nobuhiro;Nakajima Tadashi;Fujikawa Keita;Akazawa Manabu
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Type?2 diabetes mellitusClaims-based cohort evidenceDiagnosisTreatment coursePhysician visit;
83.Bempedoic Acid: The New Kid on the Block for the Treatment of Dyslipidemia and LDL Cholesterol: A Narrative Review

机译：Bempedo酸：用于治疗血脂血症和LDL胆固醇的嵌段新的孩子：叙事审查
- 作者：Alam Uazman;Al-Bazz Dalal Y.;Soran Handrean
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Atherosclerotic cardiovascular diseaseBempedoic acidDiabetesDyslipidaemiaStatins;
84.Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications

机译：两种智能手机应用的碳水化合物计数准确性的预期独立评价
- 作者：Joubert Michael;Meyer Laurent;Doriot Aline;Dreves Bleuenn;Jeandidier Nathalie;Reznik Yves
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Carbohydrate countingFlexible insulin therapySmartphone applicationsType 1 diabetes;
85.A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients

机译：基于指南的决策树在中国糖尿病患者的3个月内通过较少的低血糖症实现更好的葡萄糖对照
- 作者：Luo Yingying;Wu Hong;Liao Xiyang;Zhao Tingting;Cui Nan;Li Aihua;Sun Xingzhi;Zhang Puhong;Huang Yahua;Zhang Xia;Yin Huiqiu;Ji Linong
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Decision treeGuidelineDiabetesGlucose controlHypoglycemia;
86.Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet? Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial

机译：通过改变ILET中的TMAX设置来实现血糖控制的改善？使用快速作用胰岛素Aspart时的仿生胰腺：随机试验
- 作者：Russell Steven J.;Balliro Courtney;Ekelund Magnus;El-Khatib Firas;Graungaard Tina;Greaux Evelyn;Hillard Mallory;Jafri Rabab Z.;Rathor Naveen;Selagamsetty Raj;Sherwood Jordan;Damiano Edward R.
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- AlgorithmAutomated deliveryBionic pancreasFaster aspartGlucose controlInsulinType 1 diabetes;
87.The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

机译：Covid-19锁定对糖尿病人的代谢控制和医疗保健的影响：Confi-Diab横截面研究
- 作者：Ludwig Lisa;Scheyer Nicolas;Remen Thomas;Guerci Bruno
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- COVID-19DiabetesHealthcare consumptionLockdownMetabolic controlTelemedicine;
88.Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type?2 Diabetes and High Risk of Cardiovascular Disease in Thailand

机译：Dapagliflozin作为泰国型糖尿病患者的标准治疗达到标准治疗的成本实用性分析及泰国心血管疾病的高风险
- 作者：Deerochanawong Chaicharn;Vareesangthip Kriengsak;Piyayotai Dilok;Thongsuk Dittaya;Pojchaijongdee Nuch;Permsuwan Unchalee
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Cardiovascular diseaseChronic kidney diseaseDapagliflozinDiabetesSGLT2 inhibitor;
89.Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study

机译：基线特征对胰岛素肺碱100 u / ml的低血糖风险的影响：超高7研究后的HOC分析
- 作者：Wan Hailong;Wen Binhong;Wang Xueying;Wang Junfen;Zhang Yunliang;Ning Tao;Duan Binhong;Li Yufang;Feng Wei;Zhang Xia;Cui Nan;Ji Linong
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- Baseline characteristicsHypoglycaemiaInsulin glargineType 2 diabetes;
90.Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis

机译：二甲双胍不同配方的疗效和副作用谱：系统综述和荟萃分析
- 作者：Tarry-Adkins Jane L.;Grant Imogen D.;Ozanne Susan E.;Reynolds Rebecca M.;Aiken Catherine E.
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- DiabetesEfficacyMetforminPolycystic ovarian syndromeSide effects;
91.The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond

机译：对欧洲糖尿病患者的遥测工具的挑战：Covid-19及以后的课程
- 作者：Choudhary Pratik;Bellido Virginia;Graner Matthijs;Altpeter Bernd;Cicchetti Americo;Durand-Zaleski Isabelle;Kristensen Finn B?rlum
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- eHealthTelemedicineTelemonitoringType 1 diabetesType 2 diabetesContinuous glucose monitoringCOVID-19;
92.Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future

机译：大流行期间的远程观点，远程医疗和范围内的时间：糖尿病患者未来糖尿病风险管理的范式变化
- 作者：Danne Thomas;Limbert Catarina;Puig Domingo Manel;Del Prato Stefano;Renard Eric;Choudhary Pratik;Seibold Alexander
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- DiabetesInsulin pumpsContinuous glucose monitoringAmbulatory glucose profileVirtual careCOVID-19MortalityRisk managementTelemonitoringTelemedicine;
93.Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type?2 Diabetes

机译：口服葡萄糖耐量检测期间的葡萄糖峰值时间与患者患者患者患者患者2糖尿病患者治疗后的胰岛素分泌和胰岛素敏感性的变化有关
- 作者：Jiang Yanqiu;Cui Shiwei;Zhang Rongping;Zhao Xiaoqin;Yao Lili;OuYang Rong;Chen Wei;Zhou Ranran;Zhao Xuying;Tang Zhuqi;Yuan Jin;Yuan Jie;Qian Chen;Huang Ping;Gu Yunjuan;Wang Xinlei
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- ExenatideGlucose peak timeHypoglycemic agentsOral glucose tolerance testType?2 diabetes;
94.Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type?2 Diabetes

机译：使用数字跟踪器的葡萄糖调节和健康成人的连续葡萄糖监测和2型糖尿病
- 作者：Dehghani Zahedani Ashkan;Shariat Torbaghan Solmaz;Rahili Salar;Karlin Kirill;Scilley Darrin;Thakkar Riya;Saberi Maziyar;Hashemi Noosheen;Perelman Dalia;Aghaeepour Nima;McLaughlin Tracey;Snyder Michael P.
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Continuous glucose monitorDiabetesDigital healthPrediabetesTime in range;
95.Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study

机译：二甲双胍和二肽肽肽酶-4抑制剂在日本肥胖患者2型糖尿病患者中的比较效果：索赔数据库研究
- 作者：Odawara Masato;Aoi Sumiko;Takeshima Tomomi;Iwasaki Kosuke
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- Body mass indexDatabase researchDipeptidyl peptidase-4 inhibitorsGlycemic controlMetforminObesityType 2 diabetes;
96.Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas

机译：磺脲类在目前的2型糖尿病管理中的实践中：它们都是一样的吗？来自海湾合作委员会（GCC）国家顾问委员会的苏磺酰脲
- 作者：Al-Saleh Yousef;Sabico Shaun;Al-Furqani Ahmed;Jayyousi Amin;Alromaihi Dalal;Ba-Essa Ebtesam;Alawadi Fatheya;Alkaabi Juma;Hassanein Mohamed;Al-Sifri Saud;Saleh Seham;Alessa Thamer;Al-Daghri Nasser M.
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- Type 2 diabetesSulfonylureaGliclazideMiddle East;
97.Glucagon-Like Peptide?1 Receptor Agonist Usage in Type?2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review

机译：胰高血糖素类肽？1受体激动剂在英国及以后的初级保健中的2型糖尿病：叙述审查
- 作者：Fernando Kevin;Bain Stephen C.;Holmes Patrick;Jones Philip Newland;Patel Dipesh C.
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- Clinical guidanceGlucagon-like peptide?1 receptor agonistGlucose-lowering medicinesPrescribing toolsPrimary careRisk/benefitTherapy choiceType?2 diabetes;
98.Treatment Patterns, Effectiveness, and Satisfaction Among Patients with Type?2 Diabetes Treated with Insulin in Saudi Arabia: Results of the RIMODIS Study

机译：在沙特阿拉伯胰岛素治疗的患者患者的治疗模式，有效性和满意度：Rimodis研究的结果
- 作者：AlSlail Fatima Y.;Akil Yasser A.
- 期刊名称：《Diabetes therapy》 | 2021年第7期
- Antidiabetic therapyClinical managementGlycemic controlSaudi ArabiaType?2 diabetes;
99.The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study

机译：基于密集型教育教育的康复议定书的耐久性，用于最佳胰岛素注射实践：isterp-2研究
- 作者：Gentile Sandro;Guarino Giuseppina;Della Corte Teresa;Marino Giampiero;Satta Ersilia;Pasquarella Maria;Romano Carmine;Alfrone Carmelo;Giordano Laura;Loiacono Fabrizio;Capace Maurizio;Lamberti Rossella;Strollo Felice
- 期刊名称：《Diabetes therapy》 | 2021年第9期
- Type 2 diabetesInjection techniqueEducationRehabilitationLipohypertrophyHypoglycemia;
100.Differential Cost-Sharing Undermines Treatment Adherence to Combination Therapy: Evidence from Diabetes Treatment

机译：差分成本分享破坏治疗依从性疗法：来自糖尿病治疗的证据
- 作者：Nelson David R.;Heaton Pamela;Hincapie Ana;Ghodke Shirin;Chen Jieling
- 期刊名称：《Diabetes therapy》 | 2021年第8期
- AdherenceHealthcare out-of-pocket costsDiabetes combination therapyInsurance designMedical Expenditure Panel Survey (MEPS);

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号